
Nausheen Ahmed MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Associate Professor
Join to view full profile
2330 Shawnee Mission PkwyStop 5003Westwood, KS 66205
Phone+1 913-588-9832
Fax+1 423-408-7405
Dr. Ahmed is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nausheen Ahmed is a Hematologist based in Westwood, KS with subspecialties in Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, and Sickle Cell & Other Anemias. She completed her residency in Internal Medicine at the University of Connecticut, followed by fellowships in Hematology and Medical Oncology at UMass Chan and Case Western Reserve University respectively. Since 2019, she has been working as a Clinical Fellow at UH Cleveland Medical Center. Dr. Ahmed’s research, including studies on hematopoietic cell transplantation, CAR T cell therapy, and checkpoint inhibition in aggressive B-cell lymphomas, has been extensively published in professional journals. Among her several articles, one has been cited by four other publications.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
UMass Chan - BaystateFellowship, Hematology and Medical Oncology, 2012 - 2015
Aga Khan Medical CollegeClass of 2003
Western Reserve Health Education/NEOMEDResidency, Family Medicine
University of ConnecticutResidency, Internal Medicine
Certifications & Licensure
OH State Medical License 2017 - 2028
KS State Medical License 2020 - 2027
MO State Medical License 2021 - 2027
TN State Medical License 2015 - 2019
VA State Medical License 2015 - 2018
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.Cassandra Duarte, Grace N Bosma, Diana Abbott, Gaston Jean-Louis, Maciej Kabat
European Journal of Haematology. 2026-09-18 - Correction: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.Doris K Hansen, Danai Dima, Hira Mian, Jakob Devos, Ruta Brazauskas
Blood Cancer Journal. 2026-08-31 - Masked divergence in cancer mortality following COVID-19 disruption.Mohammad Ahsen Soomro, Amy Varghese, Hala Soomro, Al-Ola Abdallah, Forat G Lutfi
Cancer Epidemiology. 2026-08-01
Press Mentions
After Revolutionizing Blood Cancer Care, CAR-T Therapy Takes Aim at Solid TumorsAugust 18th, 2025
Expanding Access to CAR T-cell TherapyJuly 17th, 2025
Should FDA’s Toxicity Guidance for CAR-T Be Changed?August 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: